British Journal of Haematology

Metastatic melanoma in the marrow: a black and white diagnosis
pp. 1-1(1)
Authors: Bhandari, Sandeep; Jack, Fergus; Hussain, Kudair; Bell, Andrew

Bone marrow metastasis in gastro-intestinal stromal tumour
pp. 2-2(1)
Authors: Bajel, Ashish; Simpson, Ian; Longano, Anthony; Roy, Sukanya; Richardson, Gary

Acute megakaryoblastic leukaemia (AMKL) and transient myeloproliferative disorder (TMD) in Down syndrome: a multi-step model of myeloid leukaemogenesis
pp. 3-12(10)
Authors: Roy, Anindita; Roberts, Irene; Norton, Alice; Vyas, Paresh

Advances in the management and monitoring of extranodal NK/T-cell lymphoma, nasal type
pp. 13-21(9)
Author: Liang, Raymond

UK Myeloma Forum (UKMF) and Nordic Myeloma Study Group (NMSG): guidelines for the investigation of newly detected M-proteins and the management of monoclonal gammopathy of undetermined significance (MGUS)
pp. 22-42(21)
Authors: Bird, Jenny; Behrens, Judith; Westin, Jan; Turesson, Ingemar; Drayson, Mark; Beetham, Robert; D'Sa, Shirley; Soutar, Richard; Waage, Anders; Gulbrandsen, Nina; Gregersen, Henrik; Low, Eric

Guidelines for the diagnosis and management of aplastic anaemia
pp. 43-70(28)
Authors: Marsh, Judith C. W.; Ball, Sarah E.; Cavenagh, Jamie; Darbyshire, Phil; Dokal, Inderjeet; Gordon-Smith, Edward C.; Keidan, Jane; Laurie, Andrew; Martin, Anna; Mercieca, Jane; Killick, Sally B.; Stewart, Rhona; Yin, John A. L.

Stem cell donation - What advice can be given to the donor?
pp. 71-76(6)
Authors: Pamphilon, Derwood; Siddiq, Samreen; Brunskill, Susan; Dorée, Carolyn; Hyde, Chris; Horowitz, Mary; Stanworth, Simon

Acquired coagulation disorders: revisited using global coagulation/anticoagulation testing
pp. 77-82(6)
Authors: Tripodi, Armando; Chantarangkul, Veena; Mannucci, Pier M.

Mantle cell lymphoma with central nervous system involvement: frequency and clinical features
pp. 83-88(6)
Authors: Gill, Saar; Herbert, Kirsten E.; Prince, H. Miles; Wolf, Max M.; Wirth, Andrew; Ryan, Gail; Carney, Dennis A.; Ritchie, David S.; Davies, John M.; Seymour, John F.

Phase I trial of fludarabine, bortezomib and rituximab for relapsed and refractory indolent and mantle cell non-Hodgkin lymphoma
pp. 89-96(8)
Authors: Barr, Paul M.; Fu, Pingfu; Lazarus, Hillard M.; Horvath, Nancy; Gerson, Stanton L.; Koc, Omer N.; Bahlis, Nizar J.; Snell, Michael R.; Dowlati, Afshin; Cooper, Brenda W.

Preliminary evidence of disease response to the pan deacetylase inhibitor panobinostat (LBH589) in refractory Hodgkin Lymphoma
pp. 97-101(5)
Authors: Dickinson, Michael; Ritchie, David; DeAngelo, Daniel J.; Spencer, Andrew; Ottmann, Oliver G.; Fischer, Thomas; Bhalla, Kapil N.; Liu, Angela; Parker, Katie; Scott, Jeffrey W.; Bishton, Mark; Miles Prince, H.

Origin and fate of blood cells deficient in glycosylphosphatidylinositol-anchored protein among patients with bone marrow failure
pp. 102-112(11)
Authors: Sugimori, Chiharu; Mochizuki, Kanako; Qi, Zhirong; Sugimori, Naomi; Ishiyama, Ken; Kondo, Yukio; Yamazaki, Hirohito; Takami, Akiyoshi; Okumura, Hirokazu; Nakao, Shinji

Extended triple intrathecal therapy in children with T-cell acute lymphoblastic leukaemia: a report from the Israeli National ALL-Studies
pp. 113-124(12)
Authors: Stark, Batia; Avrahami, Galia; Nirel, Ronit; Abramov, Aya; Attias, Dina; Ballin, Ami; Bielorai, Bella; Burstein, Yoav; Gavriel, Hertzel; Elhasid, Ronit; Kapelushnik, Joseph; Sthoeger, Dalia; Toren, Amos; Wientraub, Michael; Yaniv, Isaac; Izraeli, Shai

International variations in infection supportive care practices for paediatric patients with acute myeloid leukaemia
pp. 125-128(4)
Authors: Lehrnbecher, Thomas; Ethier, Marie-Chantal; Zaoutis, Theoklis; Creutzig, Ursula; Gamis, Alan; Reinhardt, Dirk; Aplenc, Richard; Sung, Lillian

Long-term survival and late relapse in 2-year survivors of autologous haematopoietic cell transplantation for Hodgkin and non-Hodgkin lymphoma
pp. 129-139(11)
Authors: Majhail, Navneet S.; Bajorunaite, Ruta; Lazarus, Hillard M.; Wang, Zhiwei; Klein, John P.; Zhang, Mei-Jie; Rizzo, J. Douglas

A novel association between a SNP in CYBRD1 and serum ferritin levels in a cohort study of HFE hereditary haemochromatosis
pp. 140-149(10)
Authors: Constantine, Clare C.; Anderson, Greg J.; Vulpe, Chris D.; McLaren, Christine E.; Bahlo, Melanie; Yeap, Heng Lin; Gertig, Dorota M.; Osborne, Nicholas J.; Bertalli, Nadine A.; Beckman, Kenneth B.; Chen, Victoria; Matak, Pavel; McKie, Andrew T.; Delatycki, Martin B.; Olynyk, John K.; English, Dallas R.; Southey, Melissa C.; Giles, Graham G.; Hopper, John L.; Allen, Katrina J.; Gurrin, Lyle C.

Characterisation of the British α⁰-thalassaemia deletion: evidence of a founder effect in Newfoundland, Canada
pp. 150-152(3)
Authors: Eng, Barry; Greenlay, Benjamin; Waye, John S.

The role of tyrosine kinase inhibitors in tuberous sclerosis
pp. 152-153(2)
Authors: Koluman, Başak; Yegin, Zeynep Arzu; Yağcı, Münci

Impaired neutrophil migration and phagocytosis in IRAK-4 deficiency
pp. 153-156(4)
Authors: Bouma, Gerben; Doffinger, Rainer; Patel, Smita Y.; Peskett, Emma; Sinclair, Joanna C.; Barcenas-Morales, Gabriela; Cerron-Gutierrez, Lourdes; Kumararatne, Dinakantha S.; Graham Davies, E.; Thrasher, Adrian J.; Burns, Siobhan O.

Corrigendum
pp. 157-157(1)